Company Monitoring Page for Allergan

latest headlines for company on cafepharma

How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
Motley Fool
Mon, 02/10/20 - 11:39 pm
Tags:
Allergan, earnings
Aerie Pharmaceuticals hires former Allergan, Alcon exec to help lead clinical, medical affairs
Fierce Biotech
Mon, 02/3/20 - 10:35 am
Tags:
Aerie Pharmaceuticals, Allergan, Alcon, medical affairs
Lilly's migraine reliever Reyvow cleared for launch, beating Allergan's rival Ubrelvy to market
Fierce Pharma
Fri, 01/31/20 - 12:14 pm
Tags:
migraines, Eli Lilly, Reyvow, Allergan, Ubrelvy
Allergan, Merck KGaA and Sai Life Sciences Invest in New Global Manufacturing Facilities
BioSpace
Thu, 01/30/20 - 10:48 am
Tags:
Allergan, Merck KGaA, Sai Life Sciences, drug manufacturing
Allergan unveils new Botox plant ahead of $63B AbbVie merger
Fierce Pharma
Tue, 01/28/20 - 12:02 pm
Tags:
AbbVie, Allergan, Botox, Ireland, drug manufacturing
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Xconomy
Mon, 01/27/20 - 10:57 am
Tags:
Allergan, AbbVie, AstraZeneca, M&A, Nestle
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
Fierce Pharma
Fri, 01/10/20 - 11:55 pm
Tags:
AbbVie, Allergan, antitrust, M&A, brazikumab, Europe
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
Tags:
M&A, AbbVie, Allergan, Astellas, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
AbbVie answers Allergan aesthetics worries with separate new unit
Fierce Pharma
Wed, 01/8/20 - 12:16 pm
Tags:
AbbVie, Allergan, aesthetics, M&A, Allergan Aesthetics
Overview: CRISPR Technology Headed to Clinical Trials
BioSpace
Wed, 01/8/20 - 10:33 am
Tags:
CRISPR, Editas Medicine, clinical trials, Allergan, LCA10
Should AbbVie break up Allergan? If it wants to make up for Humira, then yes, analyst says
Fierce Pharma
Tue, 01/7/20 - 10:49 pm
Tags:
AbbVie, Allergan, M&A, Humira, Botox
In last-minute deal, Allergan forks over a hefty $300M to settle pay-for-delay dispute
Fierce Pharma
Mon, 01/6/20 - 11:32 pm
Tags:
AbbVie, Allergan, M&A, pay-for-delay, Warner Chilcott, Watson Pharmaceuticals
Novartis, Merck and Allergan raise drug prices to start 2020, joining Big Pharma peers
Fierce Pharma
Mon, 01/6/20 - 10:46 am
Tags:
drug pricing, Merck, Allergan, Novartis
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
Tags:
M&A, Bristol-Myers Squibb, Celgene, AbbVie, Allergan, Roche, Spark Therapeutics, Novartis, The Medicines Company, Alkermes, Rodin Therapeutics, Sumitomo Dainippon, Roivant
Allergan scores year-end FDA nod for CGRP migraine med Ubrelvy, plans early 2020 launch
Fierce Pharma
Mon, 12/23/19 - 11:56 pm
Tags:
Allergan, UIbrelvy, ubrogepant, FDA, migraines, CGRPs
Amgen, Allergan join Rituxan biosimilar challenge with FDA filing
Pharmaforum
Fri, 12/20/19 - 12:15 pm
Tags:
Amgen, Allergan, biosimilar, Roche, Rituxan
After big M&A year, will pharma move away from massive deals in 2020?
Fierce Pharma
Mon, 12/16/19 - 10:29 pm
Tags:
M&A, Sanofi, Merck, AbbVie, Allergan, Bristol-Myers Squibb, Celgene, FTC
3 Biotechs Facing FDA Approvals by Year's End
Motley Fool
Mon, 12/9/19 - 09:45 am
Tags:
FDA, Amgen, Vascepa, Allergan, migraines, ubrogepant, Intra-Cellular Therapies, lumateperone, schizophrenia
Go or no go? Vascepa’s finale and Allergan's pain relief
EP Vantage
Mon, 12/2/19 - 10:37 am
Tags:
FDA, Amarin, Vascepa, Allergan, migraines, ubrogepant
Before 2019 closes, the FDA has 3 key approval decisions to make
Biopharma Dive
Wed, 11/27/19 - 12:43 pm
Tags:
Allergan, ubrogepant, migraines, Amarin, Vascepa, Intra-Cellular Therapeutics, lumateperone, schizophrenia, bipolar disorder, drug approvals, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.